Cytokine Suppression
Cytokine Suppression - Related Videos
08:34
The Measurement and Treatment of Suppression in Amblyopia
0 Views •
Cited by 54 •
2012
Amblyopia is a developmental disorder of the visual cortex that is often accompanied by strong suppression of one eye. We present a new technique for measuring and treating interocular suppression in patients with amblyopia that can be deployed using virtual reality goggles or a portable iPod Touch device.
08:32
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
0 Views •
Cited by 2 •
2014
We describe a protocol to measure the antiviral cytokine production in mice infected with a model herpesvirus, murine gamma herpesvirus 68 (γHV68) that is closely-related to human Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). Utilizing genetically modified mouse strains and mouse embryonic fibroblasts (MEFs), we assessed the antiviral cytokine production both in vivo and ex vivo. “Reconstituting” the expression of innate immune components in knockout embryonic...
12:58
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
0 Views •
Cited by 2 •
2017
Described here is a method for producing exogenous cytokine in patient-derived xenograft (PDX) mice via weekly intraperitoneal injection of a cytokine-transduced stromal cell line. This method broadens the utility of PDX and provides the option for transient or sustained exogenous cytokine delivery in a multitude of PDX models.
02:57
Assessing Antiviral Cytokine Production in Response to Viral Infection
0 Views •
2026
Source: Zhang, J., et al. Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production. J. Vis. Exp. (2014)This video demonstrates the process of infecting murine fibroblast cells with herpesvirus and monitoring the resulting antiviral cytokine release and gene expression. It outlines key steps, including viral infection, media collection for cytokine quantification, and cell harvesting for gene expression analysis.
04:29
Visualizing Transcriptional Suppression in Virus-Infected Cells
0 Views •
2026
Source: Kalveram, B. et al. Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis. J. Vis. Exp. (2013)This video demonstrates the use of click chemistry and fluorescence microscopy to visualize nascent RNA transcription in mammalian cells. It highlights how viral infection suppresses host transcription by comparing fluorescent signals between infected and control cells.
FAQs
It can act at several points in the inflammatory pathway: limiting cytokine production or release, preventing cytokines from binding their receptors, or blocking downstream signaling programs activated by receptor engagement. These distinct intervention points can reduce inflammatory activity even when cytokines have already been produced, helping control immune responses that might otherwise promote excessive tissue injury.
These approaches target inflammatory activity through different types of intervention. Corticosteroids provide a broad means of reducing immune-driven inflammation, whereas small-molecule inhibitors interrupt selected intracellular pathways. Antibodies can neutralize a specific cytokine or block its receptor. Their differing target ranges help explain why cytokine suppression can be designed as either broader pathway control or more focused blockade.
Cytokines contribute not only to harmful inflammation but also to normal host defense. Excessive suppression may therefore interfere with protective immune functions, while insufficient suppression may leave inflammatory tissue damage uncontrolled. The central therapeutic challenge is to reduce damaging immune activity without eliminating the cytokine-dependent responses needed to defend the body.
The intervention can be directed toward cytokine production, release, receptor binding, or downstream signaling. Targeting these different stages changes how broadly the inflammatory response is affected and whether a particular cytokine or its receptor is neutralized. This pathway-based distinction provides a framework for matching the suppression strategy to the need for general control or selective interruption.
In medicine, cytokine suppression is used to help manage autoimmune and inflammatory disorders, where excessive immune activity contributes to disease. It can also help prevent transplant rejection and limit tissue damage associated with uncontrolled inflammation. These applications reflect the same therapeutic goal: controlling harmful immune signaling while retaining enough protective function for host defense.
Treatment aims to reduce excessive inflammatory activity, lessen immune-mediated tissue damage, and, in transplantation, help prevent rejection. The desired outcome is not complete elimination of immune signaling, because cytokines also support normal defense. Instead, successful application depends on achieving sufficient control of damaging inflammation while preserving protective immune responses.